(Q46938081)

26 December 2017

title

Phase II trial of taxol in salivary gland malignancies (E1394): a trial of the Eastern Cooperative Oncology Group (English)

1 reference

26 December 2017

main subject

phase II clinical trial

0 references

1 reference

Jill Gilbert

1

1 reference

26 December 2017

Yi Li

2

1 reference

26 December 2017

Harlan A Pinto

3

1 reference

26 December 2017

Timothy Jennings

4

1 reference

26 December 2017

Merrill S Kies

5

1 reference

26 December 2017

Paula Silverman

6

1 reference

26 December 2017

Arlene A Forastiere

7

1 reference

26 December 2017

publication date

1 March 2006

1 reference

26 December 2017

published in

Head & Neck

1 reference

26 December 2017

volume

28

1 reference

26 December 2017

page(s)

197-204

1 reference

26 December 2017

issue

3

1 reference

26 December 2017

Cancers of the upper aerodigestive tract in Ontario, Canada, and the United States.

cites work

1 reference

7 January 2021

Adenoid cystic carcinoma of the head and neck

1 reference

7 January 2021

Salivary gland tumours

1 reference

7 January 2021

Adenocarcinoma of salivary origin. Clinicopathologic study of 204 patients

1 reference

7 January 2021

Cisplatin in advanced salivary gland carcinoma. A phase II study of 25 patients

1 reference

7 January 2021

Cisplatin-based chemotherapy for neoplasms arising from salivary glands and contiguous structures in the head and neck

1 reference

7 January 2021

Adriamycin/cis-platinum/cyclophosphamide combination chemotherapy for advanced carcinoma of the parotid gland

1 reference

7 January 2021

Cyclophosphamide, doxorubicin, and cisplatin combination chemotherapy for advanced carcinomas of salivary gland origin

1 reference

7 January 2021

Cisplatin, doxorubicin, and 5-fluorouracil chemotherapy for salivary gland malignancies: a pilot study of the Northern California Oncology Group

1 reference

7 January 2021

Phase II randomized trial comparing vinorelbine versus vinorelbine plus cisplatin in patients with recurrent salivary gland malignancies.

1 reference

7 January 2021

Relationship of mitotic arrest and apoptosis to antitumor effect of paclitaxel

1 reference

7 January 2021

Stochastic Comparison of Tests

1 reference

7 January 2021

Nonparametric Estimation from Incomplete Observations

1 reference

7 January 2021

Immunohistochemical study of epidermal growth factor receptor in adenoid cystic carcinoma of salivary gland origin

1 reference

7 January 2021

Immunohistochemical expression of epidermal growth factor receptor in salivary gland tumours

1 reference

7 January 2021

C-kit expression in the salivary gland neoplasms adenoid cystic carcinoma, polymorphous low-grade adenocarcinoma, and monomorphic adenoma

1 reference

7 January 2021

Activation of NF-kappa B requires proteolysis of the inhibitor I kappa B-alpha: signal-induced phosphorylation of I kappa B-alpha alone does not release active NF-kappa B

1 reference

7 January 2021

5-Fluorouracil suppression of NF-KappaB is mediated by the inhibition of IKappab kinase activity in human salivary gland cancer cells

1 reference

7 January 2021

HER2 expression in salivary gland carcinomas: dependence on histological subtype.

1 reference

7 January 2021

HER2/neu and Ki-67 as prognostic indicators in mucoepidermoid carcinoma of salivary glands

1 reference

7 January 2021

Identifiers

DOI

10.1002/HED.20327

1 reference

26 December 2017

PubMed ID

16470745

1 reference

26 December 2017